The Yin and Yang of Current Antifungal Therapeutic Strategies: How Can We Harness Our Natural Defenses?
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Yin and Yang of Current Antifungal Therapeutic Strategies: How Can We Harness Our Natural Defenses?
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-02-05
DOI
10.3389/fphar.2019.00080
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The effect of the novel antifungal drug F901318 (Olorofim) on the growth and viability of Aspergillus fumigatus
- (2018) Saskia du Pré et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Acylhydrazones as Antifungal Agents Targeting the Synthesis of Fungal Sphingolipids
- (2018) Cristina Lazzarini et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Evaluation of the Antifungal Activity of the Novel Oral Glucan Synthase Inhibitor SCY-078, Singly and in Combination, for the Treatment of Invasive Aspergillosis
- (2018) M. Ghannoum et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Generating anchors only to lose them: The unusual story of glycosylphosphatidylinositol anchor biosynthesis and remodeling in yeast and fungi
- (2018) Sneha Sudha Komath et al. IUBMB LIFE
- Antibodies to watch in 2018
- (2018) Hélène Kaplon et al. mAbs
- Novel mouse monoclonal antibodies specifically recognize Aspergillus fumigatus galactomannan
- (2018) Andrey L. Matveev et al. PLoS One
- Humanization of Antibodies using a Statistical Inference Approach
- (2018) Alejandro Clavero-Álvarez et al. Scientific Reports
- Antifungal drugs: New insights in research & development
- (2018) André Moraes Nicola et al. PHARMACOLOGY & THERAPEUTICS
- The antifungal pipeline: a reality check
- (2017) John R. Perfect NATURE REVIEWS DRUG DISCOVERY
- Next generation antibody drugs: pursuit of the 'high-hanging fruit'
- (2017) Paul J. Carter et al. NATURE REVIEWS DRUG DISCOVERY
- The vaccines and antibodies associated with Als3p for treatment of Candida albicans infections
- (2017) Xue Sui et al. VACCINE
- Dendritic Cells Primed with Paracoccidioides brasiliensis Peptide P10 Are Therapeutic in Immunosuppressed Mice with Paracoccidioidomycosis
- (2017) Leandro B. R. Silva et al. Frontiers in Microbiology
- Antifungal resistance: current trends and future strategies to combat
- (2017) Nathan Wiederhold Infection and Drug Resistance
- Preclinical Evaluation of the Stability, Safety, and Efficacy of CD101, a Novel Echinocandin
- (2016) Voon Ong et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The celecoxib derivative AR-12 has broad spectrum antifungal activity in vitro and improves the activity of fluconazole in a murine model of cryptococcosis
- (2016) Kristy Koselny et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The Investigational Fungal Cyp51 Inhibitor VT-1129 Demonstrates PotentIn VitroActivity against Cryptococcus neoformans and Cryptococcus gattii
- (2016) Shawn R. Lockhart et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Simultaneous Emergence of Multidrug-ResistantCandida aurison 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses
- (2016) Shawn R. Lockhart et al. CLINICAL INFECTIOUS DISEASES
- ASP2397: a novel antifungal agent produced by Acremonium persicinum MF-347833
- (2016) Ikuko Nakamura et al. JOURNAL OF ANTIBIOTICS
- Activity of a long-acting echinocandin, CD101, determined using CLSI and EUCAST reference methods, againstCandidaandAspergillusspp., including echinocandin- and azole-resistant isolates
- (2016) Michael A. Pfaller et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Cryptococcus neoformans population diversity and clinical outcomes of HIV-associated cryptococcal meningitis patients in Zimbabwe
- (2016) Tinashe K. Nyazika et al. JOURNAL OF MEDICAL MICROBIOLOGY
- Plasma membrane organization promotes virulence of the human fungal pathogen Candida albicans
- (2016) Lois M. Douglas et al. JOURNAL OF MICROBIOLOGY
- Antibodies to watch in 2017
- (2016) Janice M. Reichert mAbs
- F901318 represents a novel class of antifungal drug that inhibits dihydroorotate dehydrogenase
- (2016) Jason D. Oliver et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Combination Antifungal Therapy for Invasive Aspergillosis
- (2015) Kieren A. Marr et al. ANNALS OF INTERNAL MEDICINE
- VT-1161 Protects Immunosuppressed Mice from Rhizopus arrhizus var. arrhizus Infection
- (2015) Teclegiorgis Gebremariam et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Building a patchwork — The yeast plasma membrane as model to study lateral domain formation
- (2015) Christian Schuberth et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- In vitro activity of a Hos2 deacetylase inhibitor, MGCD290, in combination with echinocandins against echinocandin-resistant Candida species
- (2015) M.A. Pfaller et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Effect of Granulocyte-Macrophage Colony-Stimulating Factor on Prevention and Treatment of Invasive Fungal Disease in Recipients of Allogeneic Stem-Cell Transplantation: A Prospective Multicenter Randomized Phase IV Trial
- (2015) Liping Wan et al. JOURNAL OF CLINICAL ONCOLOGY
- Risk factors for fluconazole-resistant invasive candidiasis in intensive care unit patients: An analysis from the China Survey of Candidiasis study
- (2015) Xuelian Liao et al. JOURNAL OF CRITICAL CARE
- The present state of the art in expression, production and characterization of monoclonal antibodies
- (2015) Christopher L. Gaughan MOLECULAR DIVERSITY
- Comparative proteomics of atorinducibleAspergillus fumigatusmutant reveals involvement of the Tor kinase in iron regulation
- (2015) Clara Baldin et al. PROTEOMICS
- Identification of a New Class of Antifungals Targeting the Synthesis of Fungal Sphingolipids
- (2015) Visesato Mor et al. mBio
- The Aspergillus fumigatus cell wall integrity signaling pathway: drug target, compensatory pathways, and virulence
- (2015) Vito Valiante et al. Frontiers in Microbiology
- Fungal Membrane Organization: The Eisosome Concept
- (2014) Lois M. Douglas et al. Annual Review of Microbiology
- Pharmacodynamic Target Evaluation of a Novel Oral Glucan Synthase Inhibitor, SCY-078 (MK-3118), Using anIn VivoMurine Invasive Candidiasis Model
- (2014) Alexander J. Lepak et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The Clinical Candidate VT-1161 Is a Highly Potent Inhibitor of Candida albicans CYP51 but Fails To Bind the Human Enzyme
- (2014) A. G. S. Warrilow et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The Investigational Agent E1210 Is Effective in Treatment of Experimental Invasive Candidiasis Caused by Resistant Candida albicans
- (2014) Nathan P. Wiederhold et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antifungal susceptibilities of Candida glabrata species complex, Candida krusei, Candida parapsilosis species complex and Candida tropicalis causing invasive candidiasis in China: 3 year national surveillance
- (2014) Meng Xiao et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Modeling Nikkomycin Z Dosing and Pharmacology in Murine Pulmonary Coccidioidomycosis Preparatory to Phase 2 Clinical Trials
- (2014) L. F. Shubitz et al. JOURNAL OF INFECTIOUS DISEASES
- Anidulafungin and Micafungin MIC Breakpoints Are Superior to That of Caspofungin for IdentifyingFKSMutant Candida glabrata Strains and Echinocandin Resistance
- (2013) Ryan K. Shields et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Enfumafungin Derivative MK-3118 Shows IncreasedIn VitroPotency against Clinical Echinocandin-Resistant Candida Species and Aspergillus Species Isolates
- (2013) Cristina Jiménez-Ortigosa et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Human Monoclonal Antibody-Based Therapy in the Treatment of Invasive Candidiasis
- (2013) Francesca Bugli et al. Clinical & Developmental Immunology
- Increasing Echinocandin Resistance in Candida glabrata: Clinical Failure Correlates With Presence of FKS Mutations and Elevated Minimum Inhibitory Concentrations
- (2013) Barbara D. Alexander et al. CLINICAL INFECTIOUS DISEASES
- Invasive candidiasis in intensive care units in China: a multicentre prospective observational study
- (2013) F. Guo et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Fingolimod (FTY720) Stimulates Ca2+/Calcineurin Signaling in Fission Yeast
- (2013) Kanako Hagihara et al. PLoS One
- Ergosterol biosynthesis in Aspergillus fumigatus: its relevance as an antifungal target and role in antifungal drug resistance
- (2013) Laura Alcazar-Fuoli et al. Frontiers in Microbiology
- In Vitro Activity of a New Oral Glucan Synthase Inhibitor (MK-3118) Tested against Aspergillus spp. by CLSI and EUCAST Broth Microdilution Methods
- (2012) M. A. Pfaller et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The Presence of anFKSMutation Rather than MIC Is an Independent Risk Factor for Failure of Echinocandin Therapy among Patients with Invasive Candidiasis Due to Candida glabrata
- (2012) Ryan K. Shields et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Impact of Treatment Strategy on Outcomes in Patients with Candidemia and Other Forms of Invasive Candidiasis: A Patient-Level Quantitative Review of Randomized Trials
- (2012) D. R. Andes et al. CLINICAL INFECTIOUS DISEASES
- Insights into eisosome assembly and organization
- (2012) E. R. Murphy et al. JOURNAL OF BIOSCIENCES
- Comparison and Temporal Trends of Three Groups with Cryptococcosis: HIV-Infected, Solid Organ Transplant, and HIV-Negative/Non-Transplant
- (2012) Emily W. Bratton et al. PLoS One
- Tc17 Cells Mediate Vaccine Immunity against Lethal Fungal Pneumonia in Immune Deficient Hosts Lacking CD4+ T Cells
- (2012) Som Gowda Nanjappa et al. PLoS Pathogens
- Fungicidal Monoclonal Antibody C7 Interferes with Iron Acquisition in Candida albicans
- (2011) Sonia Brena et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Discovery of a Novel Class of Orally Active Antifungal β-1,3-d-Glucan Synthase Inhibitors
- (2011) Scott S. Walker et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroActivity of E1210, a Novel Antifungal, against Clinically Important Yeasts and Molds
- (2011) Mamiko Miyazaki et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Regulation of Cell Wall Biogenesis inSaccharomyces cerevisiae: The Cell Wall Integrity Signaling Pathway
- (2011) David E. Levin GENETICS
- The eisosome core is composed of BAR domain proteins
- (2011) Agustina Olivera-Couto et al. MOLECULAR BIOLOGY OF THE CELL
- Mutational Analysis of Flucytosine Resistance in Candida glabrata
- (2010) T. D. Edlind et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The lateral compartmentation of the yeast plasma membrane
- (2010) Jan Malinsky et al. YEAST
- Comparative genomics of MAP kinase and calcium–calcineurin signalling components in plant and human pathogenic fungi
- (2009) Nicolas Rispail et al. FUNGAL GENETICS AND BIOLOGY
- Variation in Susceptibility of Bloodstream Isolates of Candida glabrata to Fluconazole According to Patient Age and Geographic Location in the United States in 2001 to 2007
- (2009) M. A. Pfaller et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Activity of MGCD290, a Hos2 Histone Deacetylase Inhibitor, in Combination with Azole Antifungals against Opportunistic Fungal Pathogens
- (2009) M. A. Pfaller et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Protection by Anti-β-Glucan Antibodies Is Associated with Restricted β-1,3 Glucan Binding Specificity and Inhibition of Fungal Growth and Adherence
- (2009) Antonella Torosantucci et al. PLoS One
- Inhibition of Inositol Phosphorylceramide Synthase by the Cyclic Peptide Aureobasidin A
- (2008) P. A. Aeed et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Protein Kinase A Regulates Growth, Sporulation, and Pigment Formation in Aspergillus fumigatus
- (2008) C. Grosse et al. APPLIED AND ENVIRONMENTAL MICROBIOLOGY
- Plasma membrane microdomains regulate turnover of transport proteins in yeast
- (2008) Guido Grossmann et al. JOURNAL OF CELL BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started